175 related articles for article (PubMed ID: 22686373)
1. Duration of protective immunity and antibody responses in cattle immunised against alcelaphine herpesvirus-1-induced malignant catarrhal fever.
Russell GC; Benavides J; Grant D; Todd H; Deane D; Percival A; Thomson J; Connelly M; Haig DM
Vet Res; 2012 Jun; 43(1):51. PubMed ID: 22686373
[TBL] [Abstract][Full Text] [Related]
2. The effect of the TLR9 ligand CpG-oligodeoxynucleotide on the protective immune response to alcelaphine herpesvirus-1-mediated malignant catarrhal fever in cattle.
Parameswaran N; Russell GC; Bartley K; Grant DM; Deane D; Todd H; Dagleish MP; Haig DM
Vet Res; 2014 May; 45(1):59. PubMed ID: 24886334
[TBL] [Abstract][Full Text] [Related]
3. An immunisation strategy for the protection of cattle against alcelaphine herpesvirus-1-induced malignant catarrhal fever.
Haig DM; Grant D; Deane D; Campbell I; Thomson J; Jepson C; Buxton D; Russell GC
Vaccine; 2008 Aug; 26(35):4461-8. PubMed ID: 18601965
[TBL] [Abstract][Full Text] [Related]
4. Identification of immuno-reactive capsid proteins of malignant catarrhal fever viruses.
Bartley K; Deane D; Percival A; Dry IR; Grant DM; Inglis NF; Mclean K; Manson ED; Imrie LH; Haig DM; Lankester F; Russell GC
Vet Microbiol; 2014 Sep; 173(1-2):17-26. PubMed ID: 25091530
[TBL] [Abstract][Full Text] [Related]
5. A randomised vaccine field trial in Kenya demonstrates protection against wildebeest-associated malignant catarrhal fever in cattle.
Cook E; Russell G; Grant D; Mutisya C; Omoto L; Dobson E; Lankester F; Nene V
Vaccine; 2019 Sep; 37(40):5946-5953. PubMed ID: 31473000
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of alcelaphine herpesvirus-1 (AlHV-1) immunization with the adjuvants Emulsigen
Lankester F; Lugelo A; Werling D; Mnyambwa N; Keyyu J; Kazwala R; Grant D; Smith S; Parameswaran N; Cleaveland S; Russell G; Haig D
Vet Microbiol; 2016 Nov; 195():144-153. PubMed ID: 27771060
[TBL] [Abstract][Full Text] [Related]
7. Malignant catarrhal fever in American bison (Bison bison) experimentally infected with alcelaphine herpesvirus 2.
Taus NS; O'Toole D; Herndon DR; Cunha CW; Warg JV; Seal BS; Brooking A; Li H
Vet Microbiol; 2014 Aug; 172(1-2):318-22. PubMed ID: 24803260
[TBL] [Abstract][Full Text] [Related]
8. A field vaccine trial in Tanzania demonstrates partial protection against malignant catarrhal fever in cattle.
Lankester F; Russell GC; Lugelo A; Ndabigaye A; Mnyambwa N; Keyyu J; Kazwala R; Grant D; Percival A; Deane D; Haig DM; Cleaveland S
Vaccine; 2016 Feb; 34(6):831-8. PubMed ID: 26706270
[TBL] [Abstract][Full Text] [Related]
9. Small RNA deep sequencing identifies viral microRNAs during malignant catarrhal fever induced by alcelaphine herpesvirus 1.
Sorel O; Tuddenham L; Myster F; Palmeira L; Kerkhofs P; Pfeffer S; Vanderplasschen A; Dewals BG
J Gen Virol; 2015 Nov; 96(11):3360-3372. PubMed ID: 26329753
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of malignant catarrhal fever virus in captive wildebeest (Connochaetes sp.) in France.
Ortiz K; Javaux J; Simon M; Petit T; Clavel S; Lamglait B; Blanc B; Brunet A; Myster F; Li H; Dewals BG
Transbound Emerg Dis; 2018 Dec; 65(6):1697-1704. PubMed ID: 29962104
[TBL] [Abstract][Full Text] [Related]
11. Malignant catarrhal fever-like disease in Barbary red deer (Cervus elaphus barbarus) naturally infected with a virus resembling alcelaphine herpesvirus 2.
Klieforth R; Maalouf G; Stalis I; Terio K; Janssen D; Schrenzel M
J Clin Microbiol; 2002 Sep; 40(9):3381-90. PubMed ID: 12202582
[TBL] [Abstract][Full Text] [Related]
12. Characterization of ovine herpesvirus 2-induced malignant catarrhal fever in rabbits.
Li H; Cunha CW; Gailbreath KL; O'Toole D; White SN; Vanderplasschen A; Dewals B; Knowles DP; Taus NS
Vet Microbiol; 2011 Jun; 150(3-4):270-7. PubMed ID: 21419581
[TBL] [Abstract][Full Text] [Related]
13. Viral semaphorin inhibits dendritic cell phagocytosis and migration but is not essential for gammaherpesvirus-induced lymphoproliferation in malignant catarrhal fever.
Myster F; Palmeira L; Sorel O; Bouillenne F; DePauw E; Schwartz-Cornil I; Vanderplasschen A; Dewals BG
J Virol; 2015 Apr; 89(7):3630-47. PubMed ID: 25589653
[TBL] [Abstract][Full Text] [Related]
14. Persistence of bovine herpesvirus-1-specific antibodies in cattle after intranasal vaccination with a live virus vaccine.
Van der Poel WH; Kramps JA; Quak J; Brand A; Van Oirschot JT
Vet Rec; 1995 Sep; 137(14):347-8. PubMed ID: 8560685
[TBL] [Abstract][Full Text] [Related]
15. A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle.
van Drunen Littel-van den Hurk S; Van Donkersgoed J; Kowalski J; van den Hurk JV; Harland R; Babiuk LA; Zamb TJ
Vaccine; 1994 Nov; 12(14):1295-302. PubMed ID: 7856294
[TBL] [Abstract][Full Text] [Related]
16. The effect of dose, route and virulence of bovine herpesvirus 1 vaccine on experimental respiratory disease in cattle.
Jericho KW; Babiuk LA
Can J Comp Med; 1983 Apr; 47(2):133-9. PubMed ID: 6309347
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to malignant catarrhal fever virus in cattle with non-wildebeest-associated malignant catarrhal fever.
Rossiter PB
J Comp Pathol; 1983 Jan; 93(1):93-7. PubMed ID: 6341420
[TBL] [Abstract][Full Text] [Related]
18. Ivermectin inhibits replication of the malignant catarrhal fever virus alcelaphine herpesvirus 1.
Patho B; Grant DM; Percival A; Russell GC
Virology; 2024 Feb; 590():109958. PubMed ID: 38071929
[TBL] [Abstract][Full Text] [Related]
19. A live bovine herpesvirus-1 marker vaccine is not shed after intramuscular vaccination.
Makoschey B; Beer M
Berl Munch Tierarztl Wochenschr; 2007; 120(11-12):480-2. PubMed ID: 18085158
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
